loadpatents
name:-0.01711893081665
name:-0.0083479881286621
name:-0.0015559196472168
Holy; Chantal Patent Filings

Holy; Chantal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Holy; Chantal.The latest application filed is for "intranasal red light probe for treating alzheimer's disease".

Company Profile
1.11.14
  • Holy; Chantal - Somerville MA
  • Holy; Chantal - Raynham MA US
  • Holy; Chantal - New Brunswick NJ US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Light-based implants for treating Alzheimer's disease
Grant RE47,266 - DiMauro , et al.
2019-03-05
Red light implant for treating Parkinson's disease
Grant 8,900,284 - DiMauro , et al. December 2, 2
2014-12-02
Light-based implants for treating Alzheimer's disease
Grant 8,821,559 - DiMauro , et al. September 2, 2
2014-09-02
Intranasal red light probe for treating alzheimer's disease
Grant 8,734,498 - DiMauro , et al. May 27, 2
2014-05-27
Methods of enhancing the immune response to autoantigens in mucosal associated lymphatic tissue
Grant 7,939,078 - DiMauro , et al. May 10, 2
2011-05-10
Intranasal Red Light Probe For Treating Alzheimer's Disease
App 20110022130 - DiMauro; Thomas M. ;   et al.
2011-01-27
Method of treating or preventing osteolysis in a patient by UVB light irradiation
Grant 7,673,634 - DiMauro , et al. March 9, 2
2010-03-09
Intranasal Red Light Probe For Treating Alzheimer's Disease
App 20080221646 - DiMauro; Thomas M. ;   et al.
2008-09-11
Intranasal red light probe for treating Alzheimer's disease
Grant 7,351,253 - DiMauro , et al. April 1, 2
2008-04-01
Intranasal Delivery Of Clenbuterol Across The Cribriform Plate And Into The Brain
App 20080014152 - Di Mauro; Thomas M. ;   et al.
2008-01-17
Method Of Inducing Tolerance To Betaap 1-42 And Myelin Basic Protein
App 20080014176 - Di Mauro; Thomas M. ;   et al.
2008-01-17
Red light implant for treating Parkinson's disease
Grant 7,288,108 - DiMauro , et al. October 30, 2
2007-10-30
Red Light Implant For Treating Parkinson's Disease
App 20070239235 - DiMauro; Thomas M. ;   et al.
2007-10-11
Methods of enhancing the immune response to autoantigens in mucosal associated lymphatic tissue
App 20070010859 - DiMauro; Thomas M. ;   et al.
2007-01-11
Intranasal red light probe for treating Alzheimer's disease
App 20060287695 - DiMauro; Thomas M. ;   et al.
2006-12-21
Co-grafts for treating Parkinson's disease
App 20060269525 - Lilienfeld; Sean ;   et al.
2006-11-30
Defatted, dewatered bone marrow
App 20060251628 - Attawia; Mohamed ;   et al.
2006-11-09
Device for producing autologous VEGF
App 20060223182 - DiMauro; Thomas M. ;   et al.
2006-10-05
Red light implant for treating Parkinson's Disease
App 20060206172 - DiMauro; Thomas M. ;   et al.
2006-09-14
Th2-inducing adjuvant treatment for osteolysis
App 20060134164 - DiMauro; Thomas M. ;   et al.
2006-06-22
UV device for treating osteolysis
App 20060111291 - DiMauro; Thomas M. ;   et al.
2006-05-25
Light-based implants for treating Alzheimer's disease
App 20060100679 - DiMauro; Thomas ;   et al.
2006-05-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed